| Dec 5, 2025 |
Dec 8, 2025 |
Adverum Biotechnologies, Inc.
|
COO |
Buy |
95.0
|
+50,000
|
165.62%
|
✗
|
$211K |
| May 15, 2025 |
May 16, 2025 |
Adverum Biotechnologies, Inc.
|
COO |
Sell |
27.5
|
-2,960
|
-7.03%
|
✗
|
$5.9K |
| Mar 15, 2023 |
Mar 17, 2023 |
Adverum Biotechnologies, Inc.
|
COO |
Sell |
26.3
|
-13,360
|
-4.78%
|
✗
|
$10.4K |
| Sep 19, 2022 |
Sep 21, 2022 |
Adverum Biotechnologies, Inc.
|
Officer |
Sell |
26.3
|
-13,305
|
-4.64%
|
✗
|
$14.2K |
| Apr 19, 2022 |
Apr 20, 2022 |
Adverum Biotechnologies, Inc.
|
Officer |
Buy |
86.3
|
+21,925
|
8.48%
|
✗
|
$25K |
| Dec 8, 2021 |
Dec 10, 2021 |
Adverum Biotechnologies, Inc.
|
Officer |
Buy |
91.3
|
+25,000
|
10.70%
|
✗
|
$47.8K |
| Aug 17, 2020 |
Aug 19, 2020 |
Adverum Biotechnologies, Inc.
|
Chief Legal Officer |
Buy |
95.0
|
+7,692
|
256.40%
|
✗
|
$100K |